Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,399 | 577 | 83.0% |
| Travel and Lodging | $3,547 | 5 | 16.9% |
| Education | $26.77 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,865 | 22 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,997 | 20 | $0 (2020) |
| Abbott Laboratories | $1,510 | 31 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,442 | 31 | $0 (2024) |
| PFIZER INC. | $1,075 | 84 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,008 | 57 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $967.79 | 38 | $0 (2023) |
| Inari Medical, Inc. | $862.65 | 8 | $0 (2024) |
| BIOTRONIK INC. | $709.09 | 10 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $622.34 | 36 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,593 | 92 | Inari Medical, Inc. ($267.80) |
| 2023 | $5,866 | 89 | Edwards Lifesciences Corporation ($3,166) |
| 2022 | $2,736 | 90 | Edwards Lifesciences Corporation ($319.21) |
| 2021 | $2,260 | 54 | BIOTRONIK INC. ($413.97) |
| 2020 | $634.04 | 30 | PFIZER INC. ($156.72) |
| 2019 | $2,314 | 94 | Abbott Laboratories ($425.77) |
| 2018 | $1,758 | 73 | PFIZER INC. ($253.17) |
| 2017 | $2,813 | 63 | Medtronic Vascular, Inc. ($1,565) |
All Payment Transactions
585 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Cardiology | ||||||
| 12/10/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/09/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: DEVICES | ||||||
| 12/04/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $222.94 | General |
| Category: Lithoplasty | ||||||
| 11/26/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Genetic Disease | ||||||
| 11/21/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: DIABETES | ||||||
| 11/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | CARDIVA MEDICAL, INC. | SAVVYWIRE (Device) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: DEVICES | ||||||
| 11/07/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $3.54 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $8.44 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/31/2024 | ATRICURE, INC. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/24/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $1.38 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $31.08 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.43 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/15/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Genetic Disease | ||||||
| 10/11/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Cardiology | ||||||
| 10/10/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/09/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $1.62 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $29.47 | General |
| Category: Cardiology | ||||||
| 10/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $29.47 | General |
| Category: Cardiology | ||||||
| 10/04/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $9.69 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: DIABETES | ||||||
| 09/24/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.29 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,838 | 2,752 | $578,585 | $214,222 |
| 2022 | 20 | 1,855 | 2,681 | $567,133 | $209,707 |
| 2021 | 18 | 1,347 | 2,062 | $428,345 | $179,702 |
| 2020 | 20 | 1,040 | 1,641 | $316,353 | $144,166 |
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 370 | 763 | $120,554 | $76,441 | 63.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 121 | 244 | $61,000 | $24,243 | 39.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 121 | 134 | $92,880 | $23,217 | 25.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 32 | 32 | $35,200 | $13,089 | 37.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 86 | 91 | $25,025 | $12,240 | 48.9% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 46 | 46 | $20,700 | $8,088 | 39.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 40 | 160 | $16,800 | $7,480 | 44.5% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 45 | 89 | $71,200 | $6,494 | 9.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $9,725 | $6,157 | 63.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 82 | 86 | $20,640 | $4,852 | 23.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 24 | 26 | $11,830 | $4,436 | 37.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 67 | 67 | $17,755 | $4,256 | 24.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 293 | 344 | $17,200 | $4,010 | 23.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 21 | $6,300 | $3,316 | 52.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 12 | 69 | $10,350 | $3,282 | 31.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 11 | 70 | $8,050 | $3,051 | 37.9% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 11 | 11 | $8,800 | $2,369 | 26.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 285 | 311 | $4,301 | $2,076 | 48.3% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 11 | 14 | $9,100 | $1,956 | 21.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 27 | $3,105 | $1,799 | 57.9% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 14 | 14 | $1,260 | $305.76 | 24.3% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 11 | 11 | $2,200 | $245.19 | 11.1% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 18 | 21 | $910.00 | $238.00 | 26.2% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 18 | 21 | $420.00 | $209.40 | 49.9% |
| 93225 | Electrocardiogram (ecg) 2-day continuous | Office | 2023 | 16 | 16 | $1,760 | $193.49 | 11.0% |
About Dr. Arvind Nirula, M.D
Dr. Arvind Nirula, M.D is a Cardiovascular Disease healthcare provider based in Fountain Valley, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1437285095.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arvind Nirula, M.D has received a total of $20,973 in payments from pharmaceutical and medical device companies, with $2,593 received in 2024. These payments were reported across 585 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($17,399).
As a Medicare-enrolled provider, Nirula has provided services to 6,080 Medicare beneficiaries, totaling 9,136 services with total Medicare billing of $747,798. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Fountain Valley, CA
- Active Since 02/26/2007
- Last Updated 11/09/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437285095
Products in Payments
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $2,871
- ClosureFast (Device) $1,565
- LifeVest (Device) $1,442
- ELIQUIS (Drug) $1,424
- FLOWTRIEVER CATHETER, S (Device) $862.65
- XARELTO (Drug) $699.44
- ENTRESTO (Drug) $650.96
- VERQUVO (Drug) $577.91
- Impella (Device) $572.94
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $517.49
- SAPIEN 3 Ultra RESILIA (Device) $476.76
- JARDIANCE (Drug) $422.17
- Repatha (Biological) $364.32
- MULTAQ (Drug) $357.99
- LEQVIO (Drug) $357.45
- Confirm Rx (Device) $337.11
- Assure WCD (Device) $310.36
- CAMZYOS (Drug) $289.25
- Vascular Lithotripsy (Device) $261.59
- FARXIGA (Drug) $258.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Fountain Valley
Bao Bui, M.d, M.D
Cardiovascular Disease — Payments: $357,481
Dr. Robert Greenfield, Md, MD
Cardiovascular Disease — Payments: $67,004
Dr. Sarah Elsayed, M.d, M.D
Cardiovascular Disease — Payments: $12,248
Dr. Amanda Donohue, D.o, D.O
Cardiovascular Disease — Payments: $6,294
Tuan Nguyen, M.d, M.D
Cardiovascular Disease — Payments: $4,674
Dr. Steven Schiff, Md, Facc, Inc, MD, FACC, INC
Cardiovascular Disease — Payments: $4,122